Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure
Research to Prevent Blindness and The Glaucoma Foundation are pleased to announce a new round of grants, the Career Advancement Awards (CAAs), that support early-career researchers as they seek new knowledge related to eye diseases.
The Glaucoma Foundation (TGF) and Research to Prevent Blindness (RPB) have partnered to launch a new grant aimed at supporting under-represented racial and ethnic minority researchers in the pursuit of glaucoma research. The TGF (sponsored by Patricia Hill) / RPB Fellowships in Glaucoma provide one-year, $10,000 fellowships focused on substantive glaucoma research.
Glaucoma Research Foundation (GRF) today announced a total of $1.7 million in annual research grants to support 13 investigators at prestigious colleges and universities across the United States.
In the largest genome-wide association study of glaucoma to date, an international team of researchers compared the genes of 34,179 people with the disease to 349,321 control subjects. They identified 127 genes linked to glaucoma, including 44 new gene loci and confirmed 83 previously reported loci.
Four brief, illuminating talks by experts on gene therapy, optic nerve regeneration, the role of artificial intelligence, and the importance of trust between physician and patient.
For his research project studying neuroprotection in glaucoma, Pete Williams, PhD from the Karolinska Institutet in Stockholm was awarded the 2021 Shaffer Prize for Innovative Glaucoma Research.
The COVID-19 pandemic has presented many challenges including delayed eye doctor appointments. This video will discuss changes eye doctors have made to improve safety during every step of the office visit.
Researchers have identified a family of enzymes whose inhibition both protects neurons and encourages their growth, a pathway to potential new treatments for neurodegenerative diseases from Alzheimer’s to glaucoma.
Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health services failed to meet World Health Organization (WHO) targets.
Multiple honors recognize leadership and exemplary scientific and educational contributions
Michigan Medicine ophthalmologists create a scalable algorithm for triaging appointments during the pandemic.
Hosts Dedication for a Former Slave Who Became Country’s First African American Eye and Ear Specialist
Researchers at the University of Maryland School of Medicine (UMSOM) have for the first time identified stem cells in the region of the optic nerve, which transmits signals from the eye to the brain. The finding presents a new theory on why the most common form of glaucoma may develop and potential for new therapies.
Following a long-term diet that’s low in carbohydrates and high in fat and protein from vegetables may lower the risk of the most common subtype of glaucoma
National survey finds appointment delays and cancellations were the greatest cause of concern; waiting for in-person appointments is greatly preferred over telemedicine.
Exercise can slow or prevent the development of macular degeneration and may benefit other common causes of vision loss, such as glaucoma and diabetic retinopathy, new research suggests.
After a brain injury, cells that normally nourish nerves may actually kill them instead, a new study in rodents finds. This “reactive” phenomenon may be the driving factor behind neurodegenerative diseases like glaucoma, a leading cause of blindness.
The glaucoma specialist and researcher from Glaucoma Center of San Francisco is also a medical editor for the Gleams newsletter published by Glaucoma Research Foundation and lecturer at the annual Glaucoma 360 Symposium in San Francisco.
FOR IMMEDIATE RELEASE Contact: Ilana NikraveshMount Sinai Press [email protected] Breakthrough Technology Used to Discover Eye Damage from Repeated Intravitreal Injections Findings may lead to new treatment approaches to counteract this problem (New York, NY – April 13, 2019) – In…
GRF annual glaucoma research grants will support 12 investigators at prestigious colleges and universities across the United States.
The Shaffer Prize recognizes a researcher whose project best exemplifies the pursuit of innovative ideas in the quest to better understand and cure glaucoma.
Major surgeries such as trabeculectomy and shunts aren’t the only options for treating glaucoma when medicines and laser treatments don’t work.
Mount Sinai Doctors Share Tips for Early Detection during Glaucoma Awareness Month
The three-day event highlights innovation in glaucoma therapies to ensure patients have access to the latest and most effective diagnostic tools and treatment options.
Ophthalmology industry innovators Vicente Anido, Jr., PhD and Thomas A. Mitro of Aerie Pharmaceuticals, Inc. will be honored at the Glaucoma 360 Annual Gala on February 6, 2020 in San Francisco.
With $9.7 million in funding from the National Eye Institute, researchers at the University of Illinois at Chicago will study the impact of chronic eye disease among Latinos.
Working with the Canadian Space Agency and NASA, two Quebec-based researchers are keeping an eye on astronauts’ ocular health.